PD-001R

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NamePD-001R
Drug Alias NamePD-001RPD001R
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha degraders
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A